• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Community News

Japan stem cell scientist calls for retraction of study

Bioengineer by Bioengineer
March 11, 2014
in Community News, Stem Cells
Reading Time: 3 mins read
1
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A co-author of a Japanese study that promised a revolutionary way to create stem cells has called for the headline-grabbing research to be retracted over claims its data was faulty.

Japan stem cell scientist calls for retraction of study

Haruko Obokata, Japan’s Riken Institute researcher, announces her stem cell research at a press conference in Kobe, western Japan on January 28, 2014

The findings, published by Japanese researcher Haruko Obokata and US-based scientists, outlined a simple and low-tech approach in the quest to grow transplant tissue in the lab.

The study was touted as the third great advance in stem cells—a futuristic field that aims to reverse Alzheimer’s, cancer and other crippling or lethal diseases.

But it faced hard questions as the Japan-based Riken institute, which sponsored the study, launched a probe last month over the credibility of data used in the explosive findings.
At issue are allegations that researchers used erroneous image data for an article published in the January edition of British journal Nature.

Teruhiko Wakayama, a Yamanashi University professor who co-authored the article, called for a retraction.

“It’s hard to believe the findings anymore after so many mistakes in the data,” he told broadcaster Nippon Television late Monday.

On Tuesday, the institute said it was mulling whether to pull back the study. “We are considering whether to retract the report based on its credibility and research ethics, even though our investigation is still underway,” it said.

In an e-mailed statement, the journal said: “Issues relating to this paper have been brought to Nature’s attention and we are conducting an ongoing investigation. We have no further comment at this stage.”

But Hitoshi Niwa, who also contributed to the article, dismissed what he described as minor mistakes, Japanese media reported.

Another co-author, Charles Vacanti, a tissue engineer at Harvard Medical School and Brigham and Women’s Hospital in Boston, told the Wall Street Journal: “It would be very sad to have such an important paper retracted as a result of peer pressure, when indeed the data and conclusions are honest and valid.”
Harvard is also investigating, reports said.

Simple, low-cost technique?

Hakubun Shimomura, the Japanese minister in charge of science and education, said Tuesday that the study should be retracted now and re-published it if “they accumulate new facts” that prove its authenticity.

Called stimulus-triggered acquisition of pluripotency (STAP) cells, the innovation was touted as breaking new ground, supplying a lower-cost and relatively straightforward technique.

Stem cells are primitive cells that, as they grow, become differentiated into the various specialised cells that make up the different organs—the brain, the heart, kidney and so on.

The goal is to create stem cells in the lab and nudge them to grow into these differentiated cells, thus replenishing organs damaged by disease or accident.

The researchers’ groundbreaking findings said that white blood cells in newborn mice were returned to a versatile state through a relatively simple process that involved incubating them in a highly acidic solution for 25 minutes, followed by a five-minute spin in a centrifuge and week-long immersion in a growth culture.

Until now, only plant cells, and not mammal cells, have been found to reprogramme back to a youthful state through simple environmental factors.

A key obstacle in the field is ensuring that transplanted cells are not attacked as alien by the body’s immune system—meaning they would have to carry a patient’s own genetic code to identify them as friendly.

In 1998 came the first gain: the use of cloning technology—pioneered with Dolly the sheep—to harvest stem cells from early-stage embryos grown from the donor’s own DNA.

But these “pluripotent” stem cells are controversial as the method entails destroying the embryo, something opposed by religious conservatives and others.

In 2006, a team led by Shinya Yamanaka of Kyoto University, who was a co-recipient of the 2012 Nobel Prize for Medicine, created so-called induced pluripotent stem cells (iPS).

The team took mature cells and coded them with four genes, “rewinding” the cells’ genetic programmes to return them to a juvenile state.

The technique had to overcome an early hurdle of causing tumours in cells and still faces efficiency problems—less than one percent of adult cells are typically reprogrammed successfully.

Story Source:

The above story is based on materials provided by AFP, Kyoko Hasegawa via physorg.

Share13Tweet8Share2ShareShareShare2

Related Posts

blank

Human stem cells treat spinal cord injury side effects in mice

October 4, 2016
blank

Research into fly development provides insights into blood vessel formation

September 30, 2016

Fertility genes required for sperm stem cells

September 28, 2016

Regulatory RNA essential to DNA damage response

September 27, 2016
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    70 shares
    Share 28 Tweet 18
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

Pathology Multiplexing Revolutionizes Disease Mapping

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.